Endometrial safety and tolerability of AERODIOL(R) (intranasal estradiol) for 1 year. (Q53902287)

22 May 2018

title

Endometrial safety and tolerability of AERODIOL(R) (intranasal estradiol) for 1 year. (English)

1 reference

22 May 2018

author name string

Gompel A

1

1 reference

22 May 2018

Bergeron C

2

1 reference

22 May 2018

Jondet M

3

1 reference

22 May 2018

Dhont M

4

1 reference

22 May 2018

Van der Mooren MJ

5

1 reference

22 May 2018

Toth KS

6

1 reference

22 May 2018

Panay N

7

1 reference

22 May 2018

Von Holst T

8

1 reference

22 May 2018

publication date

1 October 2000

1 reference

22 May 2018

published in

Maturitas

1 reference

22 May 2018

volume

36

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

209-215

1 reference

22 May 2018

Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Hormonal treatment of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

1 reference

7 January 2021

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

A randomized comparison of nonoral estradiol delivery in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Acceptability and skin reactions to transdermal estrogen replacement therapy in relation to climate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Endometrial histology and bleeding patterns in post-menopausal women taking sequential, combined estradiol and dydrogesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

A dose-ranging study of the use of cyclical dydrogesterone with continuous 17 beta oestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2800%2900144-4

7 January 2021

10.1016/S0378-5122(00)00144-4

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

11063903

1 reference

22 May 2018